Do we have a chance in Poland to be treated with innovative therapies? What does a breakthrough in treatment really mean for patients?
What challenges and in terms of access to modern therapies still face patients in our country? You will learn about groundbreaking therapies, but also an innovative philosophy of treating oncological diseases in the latest The Point campaign – «Breakthrough therapies. The key to the development of medicine ».
The campaign was created for the purposes of the discussion on access to innovative medicine in Poland.
Read more today in a special supplement to Gazeta Wyborcza.
Content Partners: Polish Cancer Society, Polish Society of Clinical Oncology, Polish Society of Oncological Radiotherapy, Polish Coalition of Oncological Patients, Alivia Foundation.
Find out more:
- What does a breakthrough mean for breast cancer patients? – p. 2 – Prof. Piotr Wysocki,
- How radiotherapy is developing and changing thanks to modern technologies – p. 3 – Dr. Adam Maciejczyk,
- Is innovative medicine for Poles – p. 3 – dr Anna Zimny-Zając, Medonet
- Why is individualization of treatment in lung cancer so important? – p. 4 – Prof. Maciej Krzakowski, Prof. Rodryg Ramlau,
- What is the role of pathomorphological diagnostics in the context of metastatic non-small cell lung cancer – p. 5 – Prof. Joanna Chorostowska Wynimko,
- What plan for innovation is being prepared by the Ministry of Health – p. 8 – Deputy Minister of Health Maciej Miłkowski,
- What is the role of teamwork in the context of innovative cancer treatment? – pp. 6-7 – drug med. Marta Urbańska – Gąsiorowska
- Why do we still die because of the lack of modern therapies- p. 8 – Agata Polińska, Alivia
- What does diagnosis-appropriate therapy mean for lung cancer? – p. 9 – Prof. Jacek Fijuth
- Why a breakthrough is a hope for life – p. 9 – Alekasandra Rudnicka, PKPO
- How modern radiotherapy responds to the needs of care for the individualization of treatment and patient comfort – p. 10 – p. 11 – Tomasz Iwanicki, Elekta
- What is the role of clinical trials in terms of access to innovative therapies – p. 12 – Łukasz Więch
Medonet became the main media partner.
Read online: «Breakthrough therapies. The key to the development of medicine »